Profile data is unavailable for this security.
About the company
Earth Science Tech, Inc. is a holding company in the compounding pharmaceuticals and telemedicine sectors, through its wholly owned subsidiaries, RxCompoundStore.com, LLC. (RxCompound), Peaks Curative, LLC. (Peaks), and Earth Science Foundation, Inc. (ESF). RxCompound is a complete compounding pharmacy. RxCompound is licensed to fulfill prescriptions in the states of Florida, New York, New Jersey, Delaware, Pennsylvania, Rhode Island, Nevada, Colorado, and Arizona. Peaks is a telemedicine referral site focused on men’s health. Peaks orders are fulfilled by RxCompound. Patients who order Peaks via monthly subscription receive their refills automatically. Peaks is focused on men’s health, and, more specifically, ED. ESF accepts grants and donations to help those in need of assistance in paying for prescriptions.
- Revenue in USD (TTM)5.98m
- Net income in USD330.94k
- Incorporated2010
- Employees8.00
- LocationEarth Science Tech Inc8950 SW 74TH CT, SUITE 101MIAMI 33156United StatesUSA
- Phone+1 (786) 375-7281
- Websitehttps://www.earthsciencetech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Context Therapeutics Inc | 0.00 | -23.96m | 29.54m | 5.00 | -- | 2.49 | -- | -- | -1.50 | -1.50 | 0.00 | 0.7435 | 0.00 | -- | -- | 0.00 | -88.71 | -- | -102.79 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -61.53 | -- | -- | -- |
| Singular Genomics Systems Inc | 2.91m | -94.82m | 30.54m | 255.00 | -- | 0.1704 | -- | 10.49 | -1.30 | -1.30 | 0.04 | 2.42 | 0.0098 | 0.2182 | 3.94 | 11,415.69 | -31.96 | -- | -33.80 | -- | -19.17 | -- | -3,257.30 | -- | 9.77 | -- | 0.0474 | -- | 280.52 | -- | -4.34 | -- | -- | -- |
| Spruce Biosciences Inc | 10.09m | -47.92m | 30.63m | 29.00 | -- | 0.3992 | -- | 3.04 | -1.26 | -1.26 | 0.2622 | 1.86 | 0.1064 | -- | -- | 347,896.60 | -50.55 | -41.24 | -62.77 | -46.49 | -- | -- | -474.96 | -1,774.39 | -- | -107.65 | 0.0418 | -- | -- | -- | -3.77 | -- | -- | -- |
| Dare Bioscience Inc | 2.81m | -30.16m | 31.30m | 23.00 | -- | -- | -- | 11.15 | -0.3444 | -0.3444 | 0.032 | -0.0505 | 0.0863 | -- | 2.12 | 122,082.20 | -92.65 | -109.51 | -463.87 | -246.26 | -- | -- | -1,074.17 | -1,104.55 | -- | -- | -- | -- | -71.92 | -- | 2.54 | -- | 121.37 | -- |
| Earth Science Tech Inc | 5.98m | 330.94k | 31.49m | 8.00 | 104.17 | 14.59 | 59.49 | 5.26 | 0.001 | 0.001 | 0.0195 | 0.0069 | 3.16 | 11.41 | 106.07 | 747,970.00 | 17.50 | -224.84 | 42.70 | -- | 62.29 | 37.79 | 5.53 | -333.58 | 0.386 | -0.3899 | 0.1023 | -- | 243.77 | -36.31 | -111.95 | -- | -- | -- |
| Vicapsys Life Sciences Inc | 0.00 | -1.08m | 31.75m | 2.00 | -- | -- | -- | -- | -0.0327 | -0.0327 | 0.00 | -0.0416 | 0.00 | -- | -- | 0.00 | -364.66 | -- | -- | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- | -- | -317.25 | -- | -- | -- |
| Viracta Therapeutics Inc | 0.00 | -51.06m | 31.82m | 40.00 | -- | 2.46 | -- | -- | -1.32 | -1.32 | 0.00 | 0.4686 | 0.00 | -- | -- | 0.00 | -66.88 | -86.35 | -97.91 | -106.38 | -- | -- | -- | -11,853.94 | -- | -141.21 | 0.5798 | -- | -- | -- | -3.78 | -- | -- | -- |
| Surrozen Inc | 0.00 | -43.04m | 31.99m | 42.00 | -- | 0.5438 | -- | -- | -21.35 | -21.35 | 0.00 | 18.39 | 0.00 | -- | -- | 0.00 | -63.52 | -- | -72.56 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -19.55 | -- | -- | -- |
| NKGen Biotech Inc | 0.00 | -82.95m | 32.61m | 63.00 | -- | -- | -- | -- | -5.24 | -5.24 | 0.00 | -2.68 | 0.00 | -- | -- | 0.00 | -86.93 | -- | -111.69 | -- | -- | -- | -- | -- | -- | -0.6077 | -- | -- | -- | -- | -1,923.83 | -- | -- | -- |
| LianBio - ADR | 0.00 | -87.98m | 33.18m | 163.00 | -- | 0.1626 | -- | -- | -0.8195 | -0.8195 | 0.00 | 1.89 | 0.00 | -- | -- | 0.00 | -28.62 | -- | -35.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 43.82 | -- | -- | -- |
| Rapid Micro Biosystems Inc | 22.52m | -52.47m | 33.36m | 193.00 | -- | 0.3199 | -- | 1.48 | -1.22 | -1.22 | 0.5234 | 2.78 | 0.1348 | 1.36 | 4.07 | 116,678.80 | -31.41 | -- | -35.44 | -- | -24.36 | -- | -232.99 | -- | 5.29 | -- | 0.0026 | -- | 31.44 | -- | 13.71 | -- | -- | -- |
| China Health Industries Holdings, Inc. | 117.28k | -1.51m | 33.43m | 32.00 | -- | -- | -- | 285.00 | -0.023 | -0.023 | 0.0018 | -0.0349 | 0.0044 | 0.5692 | 25.25 | 3,665.00 | -5.72 | 3.04 | -7.60 | 3.66 | -2.37 | 69.55 | -1,287.13 | 28.61 | 0.0377 | -- | 1.68 | -- | 41,225.93 | -55.72 | -15.49 | -- | -- | -- |
| Janone Inc | 0.00 | -17.10m | 33.52m | 5.00 | -- | -- | -- | -- | -3.52 | -0.4564 | 0.00 | 2.26 | 0.00 | -- | -- | 0.00 | -52.40 | -23.12 | -96.58 | -62.22 | -- | 23.38 | -- | -30.14 | -- | -- | 0.0594 | -- | -- | -- | -313.15 | -- | -- | -- |
Data as of May 06 2024. Currency figures normalised to Earth Science Tech Inc's reporting currency: US Dollar USD
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SKY Investment Group LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
